- Overview
- Business Principles
- Events
- Corporate Governance
- Financial Information
- Stock Information
- Press Releases
- Investor Contacts
Shareholder Tools
At Ironwood, we're focused on delivering differentiated medicines to patients. If we do this efficiently and effectively, we hope to generate outstanding returns for our shareholders, inspiring their continued support so that we can create more medicines and build an enduring pharmaceutical company. These are not small goals, but we believe they represent the best way to maximize long-term value for both patients and shareholders.
Read more Hide
IR CONTACTS
Meredith Kaya
Senior Director, Investor Relations and Corporate Communications
617.374.5082
mkaya@ironwoodpharma.com
Auditors
Ernst & Young
200 Clarendon Street
Boston, MA 02116
617.266.2000
Transfer agent
Computershare Investor Services
P.O. Box 30170
College Station, TX 77842
800.662.7232
www.computershare.com
FEATURED REPORTS
2017 10-K
Feb 22, 2018
View/Download PDF Version »
2017 Proxy Statement
Apr 18, 2017
View/Download PDF Version »
Latest 10-Q
Nov 2, 2017
View Filing »
EVENTS
May 1, 2018 at 8:30 AM ET
Ironwood Pharmaceuticals 1Q 2018 Investor Update Conference Call
Read More »